E-DRUG: DNDi Annual report 2010 and Portfolio map 2011
------------------------------------------------------
Greetings from DNDi!
It is my pleasure to share with you DNDi's 2010 Annual Report (http://www.dndi.org/index.php/annual-report.html), which highlights the year's progress, offers insights into the evolution of the neglected disease landscape, and points to the expansion of DNDi's portfolio. You will find more information on the latter in our new 2011 portfolio map (http://www.dndi.org/images/stories/press_kit/about_dndi/pdfs/DNDi_portfolio%20map_2011_pdf.pdf), which has a new format and style to accompany this expansion.
While inspired and motivated by the important progress made in 2010, we know that the road ahead is long and the challenges are many. As emphasized in the Annual Report, DNDi is as strong as its partnerships and we value the collaboration and support of our partners around the world.
I thank you for joining us in our unceasing efforts to respond to the urgent needs of neglected patients.
Best regards,
Bernard Pecoul
Executive Director
Drugs for Neglected Diseases initiative (DNDi)
15 Chemin Louis-Dunant - 1202 Geneva - Switzerland
+41 22 902 92 30 (ofc)
info@dndi.org
www.dndi.org
http://twitter.com/DNDi_HQ
DNDI <dndi@dndi.org>